Related references
Note: Only part of the references are listed.Mortality due to blaKPC Klebsiella pneumoniae bacteraemia
Yedidah Fraenkel-Wandel et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Both clades of the epidemic KPC-producing Klebsiella pneumoniae clone ST258 share a modified galactan O-antigen type
Valeria Szijarto et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2016)
Molecular epidemiology of KPC-producing Klebsiella pneumoniae from invasive infections in Italy: increasing diversity with predominance of the ST512 clade II sublineage
Viola Conte et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Quantification and comparison of virulence and characteristics of different variants of carbapenemase-producing Klebsiella pneumoniae clinical isolates from Taiwan and the United States
Tsung-Ta Chiang et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2016)
Alternatives to antibiotics-a pipeline portfolio review
Lloyd Czaplewski et al.
LANCET INFECTIOUS DISEASES (2016)
Bactericidal Monoclonal Antibodies Specific to the Lipopolysaccharide O Antigen from Multidrug-Resistant Escherichia coli Clone ST131-O25b:H4 Elicit Protection in Mice
Valeria Szijarto et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Is the monoclonal spread of the ST258, KPC-3-producing clone being replaced in southern Italy by the dissemination of multiple clones of carbapenem-nonsusceptible, KPC-3-producing Klebsiella pneumoniae?
D. M. Geraci et al.
CLINICAL MICROBIOLOGY AND INFECTION (2015)
An outbreak of colistin-resistant Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae in the Netherlands (July to December 2013), with inter-institutional spread
V. Weterings et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2015)
Extensive Capsule Locus Variation and Large-Scale Genomic Recombination within the Klebsiella pneumoniae Clonal Group 258
Kelly L. Wyres et al.
GENOME BIOLOGY AND EVOLUTION (2015)
Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study
Mario Tumbarello et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Genomic Analysis of the Emergence and Rapid Global Dissemination of the Clonal Group 258 Klebsiella pneumoniae Pandemic
Jolene R. Bowers et al.
PLOS ONE (2015)
An Update of the Evolving Epidemic of blaKPC Carrying Klebsiella pneumoniae in Sicily, Italy, 2014: Emergence of Multiple Non-ST258 Clones
Celestino Bonura et al.
PLOS ONE (2015)
Carbapenem-Resistant Klebsiella pneumoniae Exhibit Variability in Capsular Polysaccharide and Capsule Associated Virulence Traits
Elizabeth Diago-Navarro et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Correlation of Klebsiella pneumoniae Comparative Genetic Analyses with Virulence Profiles in a Murine Respiratory Disease Model
Ramy A. Fodah et al.
PLOS ONE (2014)
Molecular dissection of the evolution of carbapenem-resistant multilocus sequence type 258 Klebsiella pneumoniae
Frank R. DeLeo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Risk factors for infection and predictors of mortality among patients with KPC-producing Klebsiella pneumoniae bloodstream infections in the intensive care unit
Matthaios Papadimitriou-Olivgeris et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2014)
Epidemic Klebsiella pneumoniae ST258 Is a Hybrid Strain
Liang Chen et al.
MBIO (2014)
KPC-Producing, Multidrug-Resistant Klebsiella pneumoniae Sequence Type 258 as a Typical Opportunistic Pathogen
L. S. Tzouvelekis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Risk Factors for Treatment Failure of Polymyxin B Monotherapy for Carbapenem-Resistant Klebsiella pneumoniae Infections
Yanina Dubrovskaya et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality
A. Capone et al.
CLINICAL MICROBIOLOGY AND INFECTION (2013)
Asymptomatic rectal carriage of blaKPC producing carbapenem-resistant Enterobacteriaceae: who is prone to become clinically infected?
V. Schechner et al.
CLINICAL MICROBIOLOGY AND INFECTION (2013)
Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
L. Silvia Munoz-Price et al.
LANCET INFECTIOUS DISEASES (2013)
Towards Clinical Applications of Anti-endotoxin Antibodies; A Re-appraisal of the Disconnect
James C. Hurley
TOXINS (2013)
Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K pneumoniae
Abraham Borer et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2012)
Anti-bacterial monoclonal antibodies: Back to the future?
Martin B. Oleksiewicz et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2012)
Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions
L. S. Tzouvelekis et al.
CLINICAL MICROBIOLOGY REVIEWS (2012)
Virulence and Plasmid Transferability of KPC Klebsiella pneumoniae at the Veterans Affairs Healthcare System of New Jersey
L. Kristopher Siu et al.
MICROBIAL DRUG RESISTANCE (2012)
Antibody WN1 222-5 mimics Toll-like receptor 4 binding in the recognition of LPS
Kathryn Gomery et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Current Epidemiology and Growing Resistance of Gram-Negative Pathogens
David M. Livermore
KOREAN JOURNAL OF INTERNAL MEDICINE (2012)
Molecular Characteristics of KPC-Producing Enterobacteriaceae at the Early Stage of Their Dissemination in Poland, 2008-2009
Anna Baraniak et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Monoclonal Antibodies in Infectious Diseases: Clinical Pipeline in 2011
Jan ter Meulen
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2011)
Risk Factors and Clinical Impact of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae
Leanne B. Gasink et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2009)
Oral immunization with an RfaH mutant elicits protection against salmonellosis in mice
G Nagy et al.
INFECTION AND IMMUNITY (2004)
Identification of a cross-reactive epitope widely present in lipopolysaccharide from enterobacteria and recognized by the cross-protective monoclonal antibody WN1 222-5
S Müller-Loennies et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Characterization of high affinity monoclonal antibodies specific for chlamydial lipopolysaccharide
S Müller-Loennies et al.
GLYCOBIOLOGY (2000)
Share Paper
